Search - tctmd.com

Displaying 561 - 580 of 790

Sort: Relevancy | Date

News Industry News

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience

May 17, 2016

News Daily News

Italian Registry Cautions Against TAVR in Low-Risk Patients

L.A. McKeown

May 16, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Daily News

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Todd Neale

May 12, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Conference News SCAI 2016

Minimalist Approach to Sedation Improves Early TAVR Outcomes: STS-ACC TVT Registry Analysis

L.A. McKeown

May 06, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Yael L. Maxwell

May 02, 2016

News Daily News

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Yael L. Maxwell

May 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

News Daily News

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Todd Neale

April 27, 2016

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

Advertisement

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience

Italian Registry Cautions Against TAVR in Low-Risk Patients

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Anticoagulation May Not Be Necessary When Replacing Aortic Valve With Bioprosthesis, Meta-analysis Suggests

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Minimalist Approach to Sedation Improves Early TAVR Outcomes: STS-ACC TVT Registry Analysis

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

TCTMD’s Top 10 Most Popular Stories for April 2016

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content